Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease

Neuroscience

Volumn 75, Issue 2, 1996, Pages 373-387

  Salehi, A ^a,b,c   Verhaagen, J ^a,c   Dijkhuizen, P A ^a   Swaab, D F ^a  

^a Amsterdam University Medical Center   (Netherlands)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Alzheimer; neurotrophin; NGF; nucleus basalis; trk receptors

Indexed keywords

NEUROTROPHIN; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAGNOCELLULAR NUCLEUS; MALE; MORPHOMETRICS; NERVE DEGENERATION; PRIORITY JOURNAL;

EID: 0030601663     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(96)00273-4     Document Type: Article

References (70)

1. Alderson R. F., Alterman A. L., Barde Y.-A., Lindsay R. M. Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture. Neuron. 5:1990;297-306.
2. Allen S. J., Dawbarn D., Eckford S. D., Wilcock G. K., Ashcroft M., Colebrook S. M., Feeney R., MacGowan S. H. Cloning of a non-catalytic form of human trkB and distribution of messenger RNA for trkB in human brain. Neuroscience. 60:1994;825-834.
3. Allendoerfer K. L., Cabelli R. J., Escandon E., Kaplan D. R., Nikolics K., Shatz C. J. Regulation of neurotrophin receptors during the maturation of the mammalian visual system. J. Neurosci. 14:1994;1795-1811.
4. 125I]NT-3. Eur. J. Neurosci. 6:1994;1389-1405.
5. Appel L. S. H. Unifying hypothesis for cause of amyotrophic lateral sclerosis, Parkinson and Alzheimer's disease. Ann. Neurol. 10:1981;499-505.
6. Boissière F., Hunot S., Faucheux B., Mouatt-Prigent A., Agid Y., Hirsch E. C. High affinity neurotrophin receptors in cholinergic neurons in the human brain. C. r. hebd Séanc. Acad. Sci., Paris/Life Sci. 317:1994;997-1003.
7. Chan-Palay V. Galanin hyperinnervates surviving neurons of the human basal nucleus of Meynert in dementias of Alzheimer's and Parkinson's disease: a hypothesis for the role of galanin in accentuating cholinergic dysfunction in dementia. J. comp. Neurol. 273:1988;543-557.
8. Chao M. V., Bothwell M. A., Ross A. H., Koprowski H., Lanahan A. A., Buck C. R., Sehgal A. Gene transfer and molecular cloning of the human NGF receptor. Science. 232:1986;518-521.
9. Chao M. V. Neurotrophin receptors: a window into neuronal differentiation. Neuron. 9:1992;583-593.
10. Cheng B., Mattson M. P. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Expl Neurol. 117:1992;114-123.
11. Crutcher K. A., Scott S. A., Liang S., Everson W. V., Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J. Neurosci. 13:1993;2540-2550.
12. Curtis R., Adryan K. M., Stark J. L., Park J. S., Compton D. L., Weskamp G., Huber L. J., Chao M. V., Jaenisch R., Lee K.-F., Lindsay R. M., DiStefano P. S. Differential role of the low affinity neurotrophin receptors (p75) in retrograde axonal transport of the neurotrophins. Neuron. 14:1995;1201-1211.
13. Dawbarn D., Allen S. J., Semenenko F. M. Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain. Neurosci. Lett. 94:1988;138-144.
14. Donovan M. J., Hempstead B., Julie Huber L., Kaplan D., Tsoulfas P., Chao M., Parada L., Schofield D. Identification of the neurotrophin receptors p75 and trk in a series of Wilms' tumors. Am. J. Path. 145:1994;792-801.
15. Ehlers M. D., kaplan D. R., Price D. L., Koliatsos V. E. NGF-stimulated retrograde transport of trkA in the mammalian nervous system. J. Cell Biol. 130:1995;149-156.
16. Etienne P., Robitaille Y., Wood P., Gauthier S., Nair N. P. V., Quirion R. Nucleus basalis neuronal loss, neuritic plaque and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience. 19:1986;1279-1291.
17. Frisén J., Verge V. M. K., Fried K., Risling M., Persson H., Trotter H., Hökfelt T., Lindholm D. Characterization of glial trkB receptors: differential response to injury in the central and peripheral nervous systems. Proc. natn. Acad. Sci. U.S.A. 90:1993;4971-4975.
18. Garver T. D., Oyler G. A., Harris K. A., Polavarapu R., Damuni Z., Lehman R. A., Billingsley M. L. Tau phosphorylation in brain slices: pharmacological evidence for convergence effects of protein phosphatase on tau and mitogen-activated protein kinase. Molec. Pharmac. 47:1995;745-756.
19. Goedert M., Fine A., Hunt S. P., Ulrich A. Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Molec. Brain Res. 1:1986;85-92.
20. Graham F. L., Van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
21. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons of the fimbrial transection. J. Neurosci. 6:1986;2155-2162.
22. Hefti F., Weiner W. J. Nerve growth factor and Alzheimer's disease. Ann. Neurol. 20:1986;275-281.
23. Hefti F., Mash D. F. Localization of NGF receptors in the normal brain and in Alzheimer's disease. Neurobiol. Aging. 10:1989;75-87.
24. Hefti F. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25:1994;1418-1435.
25. Hoehner J. C., Olsen L., Sandstedt B., Kaplan D. R., Påhlman S. Association of neurotrophin receptor expression and differentiation in human neuroblastoma. Am. J. Path. 147:1995;102-113.
26. Kaplan D. R., Hempstead B. L., Martine-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: a signal transducting receptor for nerve growth factor. Science. 252:1991;554-558.
27. Kaplan D. R., Martin-Zanca D., Parada L. F. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product by NGF. Nature. 350:1991;158-160.
28. Klein R., Nanduri V., Jing S., Lamballe F., Tapley P., Bryant S., CordonCardo C., Jones R., Reichardt L. F., Barbacid M. The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell. 66:1991;395-403.
29. Kleine R., Smeyne R. J., Wurst W., Long L. K., Auerbach B. A., Joyner A. L., Barbacid M. Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death. Cell. 75:1993;113-132.
30. Kleine R., Silos-Santiago I., Smeyne R. J., Lira S. A., Brambilla R., Bryant S., Zhang L., Snider W. D., Barbacid M. Disruption of the neurotrophin-3 receptor gene trkC eliminates Ia muscle afferents and results in abnormal movements. Nature. 368:1994;249-251.
31. Korsching S., Auburger G., Heumann R., Scott J., Theonen H. Levels of nerve growth factor and its mRNA in the cental nervous system of the rat correlates with cholinergic innervation. Eur. molec. Biol. Org. J. 4:1985;1389-1393.
32. Lamballe F., Klein R., Barbacid M. trkC, a new member of the family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell. 66:1991;967-979.
33. Large T. H., Bodary S. C., Clegg D. O., Weskamp G., Otten U., Reichardt L. F. Nerve growth factor gene expression in the developing rat brain. Science. 234:1986;352-355.
34. Le Gal La Salle G., Robert J. J., Berrard S., Ridoux V., Stratford-Perricaudet L. D., Perricaudet M., Mallet J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science. 259:1993;988-990.
35. MacMahon S. B., Armanini M. P., Ling L. H., Phillips H. S. Expression and coexpression of trk receptors in subpopulations of adult primary sensory neurons projecting to identified peripheral targets. Neuron. 12:1994;1161-1171.
36. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Service Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
37. Merlio J.-P., Jaber E. M., Persson H. Molecular cloning of rat trk C and distribution of cells expressing messenger RNAs for members of the trk family in the rat central nervous system. Neuroscience. 51:1992;513-532.
38. Mesulam M.-M., Van Hoesen G. W. Acetyl cholinesterase projection from the basal forebrain of the rhesus monkey to neocortex. Brain Res. 109:1976;152-157.
39. Mesulam M.-M., Mufson E. J., Levey A. I., Wainer B. H. Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata) and hypothalamus in the rhesus monkey. J. comp. Neurol. 214:1983;170-197.
40. Mobley W. C., Neve R. L., Prusiner S. B., McKinley M. P. Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid protein precursor in developing hamster brain. Proc. natn. Acad. Sci. U.S.A. 85:1988;9811-9815.
41. Morse J. K., Wiegand S. L., Anderson K. A., You Y., Cai N., DiStefano P. S., Altar C. A., Lindsay R. M., Alderson R. F. Brain-derived neurotrophin factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following a fimbria transection. J. Neurosci. 13:1993;4146-4156.
42. Mufson E. J., Presley L. N., Kordower J. H. Nerve growth factor receptor immunoreactivity within nucleus basalis (ch4) in Parkinson's disease: reduced cell number and colocalization with cholinergic neurons. Brain Res. 531:1991;19-30.
43. Mufson E. J., Conner J. M., Kordower J. H. Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis. Neuroreport. 6:1995;1063-1066.
44. Muragaki Y., Timothy N., Leight S., Hempstead B. L., Chao M. V., Trojanowski J. Q., Lee V. M.-Y. Expression of trk receptors in the developing and adult human central nervous system. J. comp. Neurol. 356:1995;387-397.
45. Murase K., Nabeshima T., Robitaille Y., Quirion R., Ogawa M., Hayashi K. NGF level is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Biochem. biophys. Res. Commun. 193:1993;198-203.
46. Ohyagi Y., Tabira T. Effects of growth factors and cytokines on expression of amyloid beta protein precursor mRNAs in cultured neural cells. Molec. Brain Res. 18:1993;127-132.
47. Olson L., Nordberg A., von Holst H., Bäckman L., Ebendahl T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A., Lundquist H., Långstron B., Meyerson B., Persson A., Viitanen M., Winblad B., Seiger Ä. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG and verbal episodic memory in Alzheimer patients. J. neural Transm. (P-D). 4:1992;79-95.
48. Parada L. F., Tsoulfas P., Tessarollo L., Blair J., Reid S. W., Soppet D. The Trk family of tyrosine kinases: receptors for NGF-related neurotrophins. Cold Spring Harbor Symp. quant. Biol. 57:1992;43-51.
49. Perry E. K. The cholinergic hypothesis 10 years on. Br. med. Bull. 42:1986;63-69.
50. Phelps C. H., Gage F. H., Growdon J. H., Hefti F., Harbaugh R., Johnston M. V., Khachaturian Z. S., Mobley W. C., Price D. L., Raskind M., Simpkins J., Thal L. J., Woodcock J. Potential use of nerve growth factor to treat Alzheimer's disease. Neurobiol. Aging. 10:1989;205-207.
51. Phillips H. S., Hains J. M., Laramee G. R., Rosenthal A., Winslow J. W. Widespread expression of BDNF but not NT3 by target areas of basal forebrain cholinergic neurons. Science. 250:1990;290-294.
52. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J.-C., Perricaudet M., Khan A. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature. 361:1993;647-650.
53. Reisberg B., Ferris X., De Leon M. J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am. J. Psychiat. 139:1982;1136-1139.
54. Richardson P. M., Issa V. M. K. V., Riopelle R. J. Distribution of neuronal receptors for nerve growth factor in the rat. J. Neurosci. 6:1986;2312-2321.
55. Rinne J. O., Paljärvi L., Rinne U. K. Neuronal size and density in the nucleus basalis of Meynert in Alzheimer's disease. J. neurol. Sci. 79:1987;6776.
56. Salehi A., Lucassen P. J., Pool C. W., Gonatas N. K., Ravid R., Swaab D. F. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience. 4:1994;871-880.
57. Scott S. A., Mufson E. J., Weingartner J. A., Skau K. A., Crutcher K. A. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15:1995;6213-6221.
58. Seiger Å., Nordberg A., Von Holst H., Bäckman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A., Lundqvist H., Långström B., Meyerson B., Persson A., Viitanen M., Winblad B., Olson B. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav. Brain Res. 57:1993;255-261.
59. Seiler M., Schwab M. E. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300:1984;33-39.
60. Shelton D. L., Reichart L. F. Studies on the expression of the β nerve growth factor (NGF) gene in the cental nervous system: levels and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. Proc. natn. Acad. Sci. U.S.A. 83:1986;2714-2718.
61. Shelton D. L., Sutherland J., Gripp J., Camerato T., Armanini M. P., Phillips H. S., Carroll K., Spencer S. D., Levinson A. D. Human trks: molecular cloning, tissue distribution, and expression of extracellular domain immunoadhesins. J. Neurosci. 15:1995;477-491.
62. Smeyne R., Klein R., Schnapp A., Long L. K., Bryant S., Lewin A., Lira S. A., Barbacid M. Severe sensory and sympathetic neuropathies in mice carrying a disturbed trk/NGF receptor gene. Nature. 368:1994;246-249.
63. Sobreviela T., Clary D. O., Reichardt L. F., Brandabur M. M., Kordower J. H., Mufson E. J. Trk-immunoreactivity profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. comp. Neurol. 350:1994;587-611.
64. Soppet D., Escandon E., Maragos J., Middlemas D. S., Reid S. W., Blair J., Burton L. E., Stanton B. R., Kaplan D. R., Hunter T., Nikolics K., Parada L. F. The neurotrophic factor brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor. Cell. 65:1991;895-903.
65. Squinto S. P., Stitt T. N., Aldrich T. H., Davis S., Bianco S. M., Radziejewski C., Glass D. J., Masiakowski P., Furth M. E., Valenzuela D. M., DiStefano P. S., Yancopoulos G. D. TrkB encodes a functional receptor for brain-derived neurotrophin factor and neurotrophin-3 but not nerve growth factor. Cell. 65:1991;885-893.
66. Sun T.-Q., Fenstermacher D. A., Vos J.-M. H. Human artificial episomal chromosomes for cloning large DNA fragments in human cells. Nature Genet. 8:1994;33-41.
67. Swaab D. F., Grundke-Iqbal I., Iqbal K., Kremer H. P. H., Ravid R., Van de Nes J. A. P. Tau and ubiquitin in human hypothalamus in aging and Alzheimer's disease. Brain Res. 590:1992;239-249.
68. Swaab D. F., Hofman M. A., Lucassen P. J., Raadsheer F. C., Van de Nes J. A. P. Functional neuroanatomy and neuropathology of the human hypothalamus. Anat. Embryol. 187:1993;317-330.
69. Van der Sluis X. X., Pool C. W., Sluiter A. A. Press-blotting on gelatin-coated nitrocellulose. A method for sensitive quantitative immunodetection of peptides after gel isoelectric focusing. J. immun. Meth. 104:1987;67-71.
70. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., Delong M. R. Alzheimer's disease and senile dementia; loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.